RhumbLine Advisers’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $25.2K | Sell |
|
|||||
|
2024
Q4 | $78.5K | Buy |
|
|||||
|
2024
Q3 | $81.1K | Sell |
|
|||||
|
2024
Q2 | $53.6K | Sell |
|
|||||
|
2024
Q1 | $252K | Buy |
|
|||||
|
2023
Q4 | $257K | Sell |
|
|||||
|
2023
Q3 | $318K | Buy |
|
|||||
|
2023
Q2 | $258K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $197K | Sell |
|
|||||
|
2020
Q4 | $115K | Buy |
|
|||||
|
2020
Q3 | $266K | Sell |
|
|||||
|
2020
Q2 | $355K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $30K | Buy |
|
|||||
|
2018
Q4 | $40K | Buy |
|
|||||
|
2018
Q3 | $64K | Sell |
|
|||||
|
2018
Q2 | $92K | Buy |
|